ArticleCell cycle (Georgetown, Tex.)2013
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
Elisa Carra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this paperpooled itcites it